Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (1) Infante Duarte, Carmen (2) Ittermann, Bernd Dr. (2) Kammertöns, Thomas Dr. (6) Kopp, Joachim Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Millward, Jason Dr. (3) Niendorf, Thoralf Prof. Dr. (3) Paul, Friedemann Prof. Dr. med. (45) Uckert, Wolfgang Prof. Dr. (2) Waiczies, Helmar Dr. (3) Waiczies, Sonia PD Dr. (2) Wanker, Erich Prof. Dr. (1) Willimsky, Gerald Dr. (6) (-) Blankenstein, Thomas Prof. Dr. (16) (-) Pezzutto, Antonio Prof. Dr. (3) AG Müller/Dechend (ECRC) (46) Ankerproteine und Signaltransduktion (1) Biobank (3) Entwicklung Mechanismus-basierter Krebstherapien (1) Experimentelle Ultrahochfeld-MR (1) Genetik und Genomik von Herz- Kreislauferkrankungen (3) Genomdiversifikation & Integrität (5) (-) Hochschulambulanz für Neuroimmunologie (1) Hypertonie-vermittelter Endorganschaden (46) Hypertonie bedingte Endorganschäden (46) Kardiale MRT (7) Magnetic Resonance (1) Mathematische Modellierung zellulärer Prozesse (1) Mathematische Zellphysiologie (6) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (2) Molekulare Epidemiologie (3) (-) Molekulare Immunologie und Gentherapie (16) Molekulare Physiologie der somatosensorischen Wahrnehmung (1) Myologie (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) (-) 2011 (6) 2012 (6) (-) 2013 (11) 2014 (4) 2015 (3) 2016 (4) 2017 (6) 2018 (5) 2019 (6) 2020 (1) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 17 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Pezzutto, Antonio Prof. Dr.Hochschulambulanz für NeuroimmunologieMolekulare Immunologie und Gentherapie 20112013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens 19. Juli 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein 13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein 15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel 07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. Januar 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
19. Juli 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
01. Dezember 2013 / Canc Med IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis M. Rothe D. Quarcoo A.A. Chashchina S.V. Bozrova Z. Qin S.A. Nedospasov T. Blankenstein T. Kammertoens M.S. Drutskaya
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. November 2011 / Eur J Immunol Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors J. Charo C. Perez C. Buschow A. Jukica M. Czeh T. Blankenstein
13. Dezember 2011 / Canc Cell Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer K. Anders C. Buschow A. Herrmann A. Milojkovic C. Loddenkemper T. Kammertoens P. Daniel H. Yu J. Charo T. Blankenstein
15. Januar 2013 / Clin Cancer Res Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes K. Anders T. Blankenstein
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
07. März 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky